BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Why Pharma and Medtech Should Digitize Quality in a Down Market

We tend to put off investments in improvements and instead opt to play it safe, taking a conservative approach to weathering the economic storm. For ...

November 01, 2022 | News | By Michelle Tanner, CFO, MasterControl

EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine

This program is funded under CEPI's 2021 call for proposals to accelerate the development of broadly protective coronavirus vaccines, which will ...

November 01, 2022 | News

FUJIFILM Diosynth Biotechnologies enters into an Agreement with Argenx

FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization for biologics, vaccines, and advanced therapies toda...

October 28, 2022 | News

CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth

New research from the CPHI Annual Report 2022 – launched during CPHI Frankfurt (1-3 November, 2022) – predicts that huge volumes of V...

October 28, 2022 | News

BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI Worldwide 2022 Conference

CPhI WW will be held in Frankfurt, Germany from November 1 to November 3, 2022. The conference will focus on product sustainability and innovation across t...

October 21, 2022 | News

With New Commitment, Gates Foundation Joins Call to Help End Polio

The new financial commitment will support implementation of the GPEI's Polio Eradication Strategy 2022-2026, which aims to end wild poliovirus in the ...

October 17, 2022 | News

Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants

Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the...

October 13, 2022 | News

Lilly receives U.S. FDA Fast Track designation for tirzepatide

Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investig...

October 11, 2022 | News

Merck Announced Its Intention To Further Expand Its Leadership in Science and Technology

“Big 3” expected to generate around 80% of sales growth and > 50% of total sales in 2025 Strategic and targeted investments for annu...

October 11, 2022 | News

Emmes (CRO) Acquires Clinical Edge

- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical in...

September 30, 2022 | News

Pall Corporation Launches Three New Allegro™ Connect Systems

Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In conjunction with Pall’s Allegr...

September 28, 2022 | News

Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor

NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the...

September 27, 2022 | News

Sciwind Biosciences and SynerK Enter into Research Partnership

The partnership combines Sciwind's expertise in disease biology and clinical development capabilities with SynerK's proprietary conjugate-based siRNA deliv...

September 27, 2022 | News

Biocytogen Expands Partnership with Merck

Under the terms of the agreement, Merck will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibo...

August 29, 2022 | News

Stay Connected